C16 Biosciences
the New York pioneer whose Palmless platform makes yeast-fermented oils and fats, backed by Breakthrough Energy Ventures and with an FDA GRAS determination that opens the route to US food-industry integration alongside its cosmetic B2B sales.
- Country
- United States
FDA GRAS
ISO 22000
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaefsareach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic palm fat | specialty-fine-chem | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.